Celestica vs. Plexus: Which EMS Stock is a Better Bet Right Now?

In This Article:

Celestica Inc. CLS and Plexus Corp PLXS are two leading players in the electronics manufacturing services (EMS) industry. Celestica is one of the largest EMS companies in the world, primarily serving original equipment manufacturers, cloud-based and other service providers, and business enterprises across several industries. The company offers a comprehensive range of manufacturing and supply-chain solutions related to design and development, new product introduction, engineering services, component sourcing, assembly, testing, systems integration and logistics.

Plexus is also a leading provider of electronic contract manufacturing services to OEMs across a wide range of industries, including Healthcare/Life Sciences, Industrial and Aerospace/Defense market sectors. Additionally, the company provides after-market services to support customers in all regions where it operates.

With domain-specific expertise in core areas, both Celestica and Plexus are strategically positioned in the EMS landscape, possessing deep industry expertise to cater to the evolving demands of business enterprises. Let us delve a little deeper into the companies’ competitive dynamics to understand which of the two is relatively better placed in the industry.

The Case for PLXS

Plexus is witnessing healthy traction in the Healthcare/Life Sciences segment, backed by growing demand for its sustaining services. Demand also remains strong in the Aerospace/Defense sector, backed by strong customer wins in the defense and space subsectors. The company’s focus on expanding its space product portfolio and engineering device services is fostering growth. A healthy number of program ramps are expected to drive the top-line performance for the company.

At the end of the second quarter, Plexus’ debt-to-capital ratio stands at 0.13 compared to the industry average of 0.46. Its current ratio is 1.53 compared to the industry average of 1.19. A current ratio above 1 suggests that a company is well-positioned to meet its short-term obligations. Its times interest earned is 9.4. Management is placing greater emphasis on operational discipline and inventory reduction to generate greater cash flow. The robust cash generation positions Plexus to invest in growth initiatives and maximize shareholder value. 

However, weakness in the Industrial sector, owing to demand softness in multiple end markets, is affecting net sales growth. The company is facing intensifying competition in the industry from Celestica, Jabil Inc. JBL and Sanmina Corporation. Moreover, the company derives a lion's share of its revenues from a few large customers. This exposes it to customer concentration risks. Given the competitive nature of the industry, the loss of any one of its key customers would significantly impact its results.